Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis |
Jennifer Chen, MD |
IGHS Faculty Affiliate, Division of Gastroenterology |
|
|
Identifying the role of opportunistic pathogens including Giardia, Cryptosporidia, Microsporidia and Mycobacterium avium |
Robert Owen, MD |
Division of Gastroenterology |
|
|
Cognitive load theory in the workplace and implications for health professions education: A critical-realist review of studies among diverse professions |
|
Division of Gastroenterology |
|
|
L-Carnitine to Treat Fatigue Associated with Crohn's Disease |
|
Division of Gastroenterology |
|
|
UCSF IBD Fellowship 2013 - 2014 |
|
Division of Gastroenterology |
|
|
PIANO: Pregnancy in IBD and Neonatal Outcomes: In utero exposure to biologics and increased neonatal infections |
|
Division of Gastroenterology |
|
|
Dysfunctional Immune Development Among Infants Born to Mothers with IBD |
|
Division of Gastroenterology |
|
|
Impact of HIV PMTCT Interventions on HBV Disease in n HIV/HBV Co-infected Women and their Infants |
Marion Peters, MD |
Division of Gastroenterology, AIDS Research Institute |
|
|
HIV Status and Reproductive Aging Affect Liver Fibrosis in HIV/HCV Infected Women |
Marion Peters, MD |
IGHS Faculty Affiliate, Division of Gastroenterology, AIDS Research Institute |
|
|
AIDS Clinical Trials Group Network (ACTG) |
Marion Peters, MD |
IGHS Faculty Affiliate, Division of Gastroenterology |
|
|
Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) |
Marion Peters, MD |
IGHS Faculty Affiliate, Division of Gastroenterology, AIDS Research Institute |
|
|
AIDS Clinical Trials Group (ACTG), TSG Committee Chair funding |
Marion Peters, MD |
IGHS Faculty Affiliate, Division of Gastroenterology, AIDS Research Institute |
|
|
Hepatitis C: Studies of Immunity and Pathogenesis |
Kimberly Page, PhD, MPH |
Division of Gastroenterology |
|
|
Project 2: Effect of Humanized Anti Pcrv Antibody on Total Bacterial Community Composition of Adult Patients with Ventilator-Associated Pneumonia |
|
Division of Gastroenterology |
|
|
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation |
|
Division of Gastroenterology |
|
|
Sinusitis in Children and the Nasopharyngeal Microbiome |
|
Division of Gastroenterology |
|
|
Pets and the Infant Microbiome: Effect on Immune Maturation and Atopic Asthma |
|
Division of Gastroenterology |
|
|
Analysis of Urban Aerosols in Major U.S. Cities - Implications for Asthmatic Airways |
|
Division of Gastroenterology |
|
|
Prevention of Emergence of Antibiotic Resistant P. aeruginosa |
|
Division of Gastroenterology |
|
|
Sinus Microbiome Restoration Study |
|
Division of Gastroenterology |
|
|
NKT Cells Recognize and Respond to Microbes at Mucosal Surfaces |
|
Division of Gastroenterology |
|
|
Probiotic Outcomes of Enteric Microbiota |
|
Division of Gastroenterology |
|
|
Role of the Human Microbiome in Inflammatory Bowel Disease amongst Migrant South Asian Populations. |
|
Division of Gastroenterology |
|
|
Resequencing Microarray for Rapid Detection and Antimicrobial Resistance Profiling |
|
Division of Gastroenterology |
|
|
The House Dust Fungal Microbiome - Influences and Effects |
|
Division of Gastroenterology |
|
|
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network-A Longitudinal, Observational Study |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults with Compensated Chronic Hepatitis B |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
GS-US-367-1172: A Phase 3, Global, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination for 8 Weeks Compared to Sofosbuvir/Velpatasvir for 12 Weeks in Direct-Acting |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
747-303: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of beticholic Acid in Subjects with Nonalcoholic Steatohepatitis |
Mandana Khalili, MD |
IGHS Faculty Affiliate, Division of Gastroenterology |
|
|
Hepatocellular Carcinoma Screening Practices in Hepatitis B (HBV) Infected Asian Americans |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
GS-US-248-0122: A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection |
Mandana Khalili, MD |
IGHS Faculty Affiliate, Division of Gastroenterology |
|
|
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Adults with Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection |
Mandana Khalili, MD |
IGHS Faculty Affiliate, Division of Gastroenterology |
|
|
Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed |
Mandana Khalili, MD |
IGHS Faculty Affiliate, Division of Gastroenterology |
|
|
Host and Viral Predictors of Prediabetes in at-risk Latinos with Chronic Hepatitis C (HCV) |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir in Subjects with Genotype 1, 4, 5 and 6 Chronic HCV Infection Who are on Dialysis for End Stage Renal Disease |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Screening and Management of Chronic Hepatitis B Virus Infection: A Survey of San Francisco Health Care Providers |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Patients' HBV Knowledge, Attitudes, Barriers to HBV Care and HBV Treatment |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Hepatitis C Therapeutic Registry and Research Network (HCV-TARGET) |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Pegylated Interferon Lambda w/wo Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 |
Mandana Khalili, MD |
IGHS Faculty Affiliate, Division of Gastroenterology |
|
|
Alcohol's impact on immunological and virological profiles in HIV patients |
Mandana Khalili, MD |
IGHS Faculty Affiliate, Division of Gastroenterology |
|
|
Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
AI452-020-0092: Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic Hepatitis C who are Treatment-naïve or Re |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Mentoring Multidisciplinary Patient-Oriented Research in Liver Disease |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
BMS-790052 with Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis C Genotype 1 |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
BMS-790052 with Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Infected Subjects Who are Null or Partial Responders to Peginterferon Alfa plus |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
Hcv-Induced Alterations in Glucose Metabolism |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|
HBV/HIV Co-Infection Research Network |
Mandana Khalili, MD |
Division of Gastroenterology |
|
|